Cargando…
Acquired Treatment Resistance in a Patient with Metastatic PD-L1-Positive Breast Cancer and Germline BRCA1 Mutation
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer associated with higher rates of relapse and mortality compared to other subtypes. Chemotherapy has been a mainstream treatment approach for TNBC due to the lack of therapeutic targets. Recent advances have led to the intr...
Autores principales: | Kumeta, Toko, Yamaguchi, Kei, Hayami, Ryosuke, Arai, Kazumori, Tsuneizumi, Michiko, Matsunuma, Ryoichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359695/ https://www.ncbi.nlm.nih.gov/pubmed/37485016 http://dx.doi.org/10.1159/000530131 |
Ejemplares similares
-
Response of Estrogen-Receptor-Positive Metastatic Breast Cancer to Olaparib in Late-Line Therapy
por: Kumeta, Toko, et al.
Publicado: (2019) -
Concurrent Bowen's Disease of the Nipple and Breast Cancer
por: Yamaguchi, Kei, et al.
Publicado: (2020) -
Large Breast Tumor Ulceration and Quality of Life in an 80-Year-Old Woman
por: Yamaguchi, Kei, et al.
Publicado: (2021) -
Long-term response to olaparib in a patient with metastatic pancreatic cancer associated with hereditary breast and ovarian cancer syndrome
por: Tsuneizumi, Michiko, et al.
Publicado: (2022) -
Enrichment of Immune-Related Genes in Aggressive Primary Breast Angiosarcoma: A Case Report
por: Matsunuma, Ryoichi, et al.
Publicado: (2023)